chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Sneezing; Runny nose; Body aches; Fatigue; Moderate nausea/vomiting; Moderate nausea/vomiting; Soreness at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), RHINORRHOEA (Runny nose), MYALGIA (Body aches), FATIGUE (Fatigue) and NAUSEA (Moderate nausea/vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Moderate nausea/vomiting), VOMITING (Moderate nausea/vomiting) and VACCINATION SITE PAIN (Soreness at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Runny nose, at an unspecified dose and frequency. At the time of the report, SNEEZING (Sneezing) and RHINORRHOEA (Runny nose) had not resolved, MYALGIA (Body aches), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Soreness at the site of the injection) outcome was unknown and NAUSEA (Moderate nausea/vomiting) and VOMITING (Moderate nausea/vomiting) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Soreness at vaccine site; Redness at vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site). At the time of the report, VACCINATION SITE PAIN (Soreness at vaccine site) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash around her right foot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash around her right foot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash around her right foot). At the time of the report, RASH (Rash around her right foot) had not resolved.            No concomitant medications provided. It was reported that when patient received second Covid-19 shot, she got a rash around her right foot which started about two weeks after second shot. She mentioned the rash was ongoing and she was scheduled to follow up with her physician this coming week.  No treatment information provided.   This case was linked to MOD-2021-052736 (Patient Link).   Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Full blood count, Mycobacterium tuberculosis complex test, Vaccination site pain
Clinical narrative: Sore arm after the Covid-19 vaccine; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Sore arm after the Covid-19 vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriasis.    Concurrent medical conditions included Psoriasis, Tobacco user, Alcohol use and Penicillin allergy (manifested by swell up and bumps all over the body). Concomitant products included HYDROCORTISONE for Adrenal disorder NOS, LEVOTHYROXINE for Thyroid disorder NOS.   In 2017, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 40 milligram every two weeks. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. In February 2021, the patient experienced VACCINATION SITE PAIN (Sore arm after the Covid-19 vaccine). At the time of the report, VACCINATION SITE PAIN (Sore arm after the Covid-19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: no significant results found Inconclusive. On an unknown date, Mycobacterium tuberculosis complex test: no significant results found Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE PAIN (Sore arm after the Covid-19 vaccine) to be probably related.    No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site urticaria
Clinical narrative: Dose #2: Rash with pain; Dose #2:Injection site Pain; Dose #2: red..at the injection site; Dose #2:stiffness at the injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE URTICARIA (Dose #2: Rash with pain), VACCINATION SITE PAIN (Dose #2:Injection site Pain), VACCINATION SITE ERYTHEMA (Dose #2: red..at the injection site) and VACCINATION SITE INDURATION (Dose #2:stiffness at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE URTICARIA (Dose #2: Rash with pain), VACCINATION SITE PAIN (Dose #2:Injection site Pain), VACCINATION SITE ERYTHEMA (Dose #2: red..at the injection site) and VACCINATION SITE INDURATION (Dose #2:stiffness at the injection site). At the time of the report, VACCINATION SITE URTICARIA (Dose #2: Rash with pain), VACCINATION SITE PAIN (Dose #2:Injection site Pain), VACCINATION SITE ERYTHEMA (Dose #2: red.at the injection site) and VACCINATION SITE INDURATION (Dose #2:stiffness at the injection site) outcome was unknown.      Treatment of events was not reported. Concomitant medication use was not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: the injection I received consisted of less than (.2 cc) of the recommended dose; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (the injection I received consisted of less than (.2 cc) of the recommended dose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced INCORRECT DOSE ADMINISTERED (the injection I received consisted of less than (.2 cc) of the recommended dose). On 14-Jan-2021, INCORRECT DOSE ADMINISTERED (the injection I received consisted of less than (.2 cc) of the recommended dose) had resolved.            Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Paraesthesia, Post herpetic neuralgia, Pruritus
Clinical narrative: numbness; Tingling; Pain; Itching; had a significant spike in the neuralgia; This spontaneous case was reported by a consumer and describes the occurrence of POST HERPETIC NEURALGIA (had a significant spike in the neuralgia), HYPOAESTHESIA (numbness), PARAESTHESIA (Tingling), PAIN (Pain) and PRURITUS (Itching) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Post herpetic neuralgia (in left leg about 5 years ago). Concurrent medical conditions included Shingles (Recurrent, since I was 13 years old).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POST HERPETIC NEURALGIA (had a significant spike in the neuralgia). On an unknown date, the patient experienced HYPOAESTHESIA (numbness), PARAESTHESIA (Tingling), PAIN (Pain) and PRURITUS (Itching). The patient was treated with LOSARTAN ongoing since an unknown date at a dose of 25 mg; TRAZODONE at a dose of 50 mg; MELATONIN at a dose of 10 mg; COLECALCIFEROL (VIT D [COLECALCIFEROL]) at an unspecified dose and frequency and CYANOCOBALAMIN (B 12) at a dose of 2000 mg. At the time of the report, POST HERPETIC NEURALGIA (had a significant spike in the neuralgia) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed a course of steroids which unfortunately did not help.  No concomitant medication was provided.   This case was linked to MOD-2021-115893 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2021: significant follow up is added
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Headache, Influenza like illness
Clinical narrative: supper achy, like getting the flu; lost appetite; Headache; Chills; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001421A). The report describes a case of INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DECREASED APPETITE (lost appetite), HEADACHE (Headache) and CHILLS (Chills).     Concurrent medical conditions included Sickness and Ache.  On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DECREASED APPETITE (lost appetite), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (supper achy, like getting the flu), DECREASED APPETITE (lost appetite), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        No Concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-051761, MOD-2021-051761 (Patient Link).       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: No specific follow-up information recorded.
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Received the 1st dose of Moderna vaccine in error due to child is under 18 y/o; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-May-2021 and was forwarded to Moderna on 09-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the 1st dose of Moderna vaccine in error due to child is under 18 y/o) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the 1st dose of Moderna vaccine in error due to child is under 18 y/o). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the 1st dose of Moderna vaccine in error due to child is under 18 y/o) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not reported. No concomitant medications reported.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: soreness in the arm; some fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (some fatigue) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (some fatigue). At the time of the report, PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (some fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. concomitant drugs were not provided.
Age: 60.0
Sex: U
Vaccine: COVID19, UNK
Symptoms: Arthropathy, Back pain, Chondropathy, Fatigue, Illness
Clinical narrative: Hip arthropathy; Cartilage disorder; Sickness; Pain in arm; Tiredness; Nerve pain; Sacral Pain; This spontaneous case was reported by an other health care professional and describes the occurrence of ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder), ILLNESS (Sickness), NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    The patient's past medical history included Hip replacement on 23-Dec-2020. Concurrent medical conditions included Rheumatoid arthritis, Osteoarthritis, Sacral pain and Drug allergy (Morphine allergy infested by bad allergy). Concomitant products included MORPHINE for an unknown indication.   In December 2020, the patient started UPADACITINIB (RINVOQ) (unknown route) at an unspecified dose. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2020, the patient experienced NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain). On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Tiredness). On an unknown date, the patient experienced ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder) and ILLNESS (Sickness). In December 2020, NEURALGIA (Nerve pain) had resolved. In January 2021, PAIN IN EXTREMITY (Pain in arm) had resolved. In 2021, ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder) and FATIGUE (Tiredness) had resolved. At the time of the report, ILLNESS (Sickness) and BACK PAIN (Sacral Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Magnetic resonance imaging: hip joint detoriation (abnormal) Hip joint deterioration and hip joint does not have cartilages.. In December 2020, X-ray: hip joint detoriation (abnormal) Hip joint deterioration and hip joint does not have cartilages..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Tiredness) to be probably related. No further causality assessments were provided for ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder), ILLNESS (Sickness), NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain).    Non smoker  Alcohol occasionally; Sender's Comments: Very limited information regarding these events has been provided at this time. The event may probably be related to the patient's comorbidities, additional information required.
Age: 60.0
Sex: U
Vaccine: COVID19, UNK
Symptoms: Magnetic resonance imaging, Neuralgia, Pain in extremity, X-ray
Clinical narrative: Hip arthropathy; Cartilage disorder; Sickness; Pain in arm; Tiredness; Nerve pain; Sacral Pain; This spontaneous case was reported by an other health care professional and describes the occurrence of ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder), ILLNESS (Sickness), NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    The patient's past medical history included Hip replacement on 23-Dec-2020. Concurrent medical conditions included Rheumatoid arthritis, Osteoarthritis, Sacral pain and Drug allergy (Morphine allergy infested by bad allergy). Concomitant products included MORPHINE for an unknown indication.   In December 2020, the patient started UPADACITINIB (RINVOQ) (unknown route) at an unspecified dose. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2020, the patient experienced NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain). On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Tiredness). On an unknown date, the patient experienced ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder) and ILLNESS (Sickness). In December 2020, NEURALGIA (Nerve pain) had resolved. In January 2021, PAIN IN EXTREMITY (Pain in arm) had resolved. In 2021, ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder) and FATIGUE (Tiredness) had resolved. At the time of the report, ILLNESS (Sickness) and BACK PAIN (Sacral Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Magnetic resonance imaging: hip joint detoriation (abnormal) Hip joint deterioration and hip joint does not have cartilages.. In December 2020, X-ray: hip joint detoriation (abnormal) Hip joint deterioration and hip joint does not have cartilages..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Tiredness) to be probably related. No further causality assessments were provided for ARTHROPATHY (Hip arthropathy), CHONDROPATHY (Cartilage disorder), ILLNESS (Sickness), NEURALGIA (Nerve pain) and BACK PAIN (Sacral Pain).    Non smoker  Alcohol occasionally; Sender's Comments: Very limited information regarding these events has been provided at this time. The event may probably be related to the patient's comorbidities, additional information required.
Sex: M
Vaccine: COVID19
Symptoms: Ear haemorrhage
Clinical narrative: After both vaccine patient observed blood in one right side ear; blood can be feel on earbuds; This spontaneous case was reported by a consumer and describes the occurrence of EAR HAEMORRHAGE (After both vaccine patient observed blood in one right side ear; blood can be feel on earbuds) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EAR HAEMORRHAGE (After both vaccine patient observed blood in one right side ear; blood can be feel on earbuds). At the time of the report, EAR HAEMORRHAGE (After both vaccine patient observed blood in one right side ear; blood can be feel on earbuds) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received and contain non significant information.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Alcohol occasionally.  The patient's past medical history included Sacro-iliac pain, Osteoarthritis and Drug allergy (morphine allergy manifested by bad rash). Concurrent medical conditions included Non-smoker.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced PAIN IN EXTREMITY (arm soreness). In December 2020, PAIN IN EXTREMITY (arm soreness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (arm soreness) to be probably related.    No treatment and concomitant medications information was reported.   This case was linked to MOD-2021-116240 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Magnetic resonance imaging, Pain in extremity, X-ray of pelvis and hip
Clinical narrative: Arm soreness; Tiredness; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tiredness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) tablet for Rheumatoid arthritis.    The patient's past medical history included Abstains from alcohol, Hip arthropathy, Cartilage disorder, Sickness, Nerve pain in December 2020, Sacral pain (Sacral iliac pain) in December 2020, Osteoarthritis and Hip replacement on 23-Dec-2020. Concurrent medical conditions included Drug allergy (Morphine allergy manifested by bad rash).   In December 2020, the patient started UPADACITINIB (RINVOQ) (Oral) 15 mg once a day. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tiredness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Tiredness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Magnetic resonance imaging: inconclusive (Inconclusive) Inconclusive. In December 2020, X-ray of pelvis and hip: inconclusive (Inconclusive) Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events are not applicable.   This case was linked to MOD-2021-116210 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: a rash started on my other arm and spread down to the elbow; got a rash by the injection sight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (got a rash by the injection sight) and RASH (a rash started on my other arm and spread down to the elbow) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, METFORMIN, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), CITALOPRAM and TRAZODONE for an unknown indication.    On 14-Apr-2021 at 11:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021 at 8:00 AM, the patient experienced VACCINATION SITE RASH (got a rash by the injection sight). On an unknown date, the patient experienced RASH (a rash started on my other arm and spread down to the elbow). On 05-May-2021, VACCINATION SITE RASH (got a rash by the injection sight) had resolved. At the time of the report, RASH (a rash started on my other arm and spread down to the elbow) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient started using Benadryl Allergy medicine twice a day and bought Cortizone 10 to both arms.   This case was linked to MOD-2021-051681 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Malaise, Pyrexia
Clinical narrative: Feeling very weak; Headache; Felt awful; Terrible fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt awful), ASTHENIA (Feeling very weak), PYREXIA (Terrible fever) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced MALAISE (Felt awful) and PYREXIA (Terrible fever). On 06-May-2021, the patient experienced ASTHENIA (Feeling very weak) and HEADACHE (Headache). On 06-May-2021, HEADACHE (Headache) had resolved. At the time of the report, MALAISE (Felt awful), ASTHENIA (Feeling very weak) and PYREXIA (Terrible fever) outcome was unknown.            No concomitant medication provided. No treatment information provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeding disorder, Pyrexia
Clinical narrative: Not eating and drinking very little.; chills; Tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (Not eating and drinking very little.), CHILLS (chills), FATIGUE (Tired) and PYREXIA (Fever) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A.) for COVID-19 vaccination.     The patient's past medical history included Surgery (for cancer condition). Concurrent medical conditions included Cancer. Concomitant products included SIMVASTATIN for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced FEEDING DISORDER (Not eating and drinking very little.), CHILLS (chills) and FATIGUE (Tired). 03-May-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (Not eating and drinking very little.), CHILLS (chills), FATIGUE (Tired) and PYREXIA (Fever) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-238955 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Muscle spasms, Pyrexia
Clinical narrative: Spasm all over my back; back pain; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Spasm all over my back), BACK PAIN (back pain), CHILLS (Chills) and PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included MELOXICAM for Arthritis, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 28-Apr-2021, the patient experienced MUSCLE SPASMS (Spasm all over my back) and BACK PAIN (back pain). The patient was treated with PARACETAMOL (TYLENOL) for Back pain, at a dose of 3 dosage form every four hours. At the time of the report, MUSCLE SPASMS (Spasm all over my back) and BACK PAIN (back pain) had not resolved and CHILLS (Chills) and PYREXIA (Fever) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA since an unknown date.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm). At the time of the report, VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant and treatment medications were provided.   This case was linked to MOD-2021-116330 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Folow-up added on 08-JUN-2021 contains no new information.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Headache, Pyrexia, Vaccination site pain
Clinical narrative: didn't feel like to do anything/, just lying down; pain at the injection site; fever ranging form 100 -101; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (didn't feel like to do anything/, just lying down), VACCINATION SITE PAIN (pain at the injection site), PYREXIA (fever ranging form 100 -101) and HEADACHE (headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced ASTHENIA (didn't feel like to do anything/, just lying down), VACCINATION SITE PAIN (pain at the injection site), PYREXIA (fever ranging form 100 -101) and HEADACHE (headache). At the time of the report, ASTHENIA (didn't feel like to do anything/, just lying down), VACCINATION SITE PAIN (pain at the injection site), PYREXIA (fever ranging form 100 -101) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Body temperature: 100-101f (High) outcome was unknown.         Concomitant medication was not provided Treatment medication include Tylenol .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Drug interaction
Clinical narrative: IMBRUVICA OR THE CLL MADE  IT SO THAT THE COVID VACCINATION DID NOT CREATE ANTIBODIES; This spontaneous case was reported by a physician and describes the occurrence of DRUG INTERACTION (IMBRUVICA OR THE CLL MADE  IT SO THAT THE COVID VACCINATION DID NOT CREATE ANTIBODIES) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products IBRUTINIB tablet for CLL and IBRUTINIB capsule for CLL.    The patient's past medical history included No adverse event (No medical history was provided by the reporter).   On 01-Oct-2016, the patient started IBRUTINIB (Oral) dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and IBRUTINIB (Oral) 420 mg once a day. On an unknown date, the patient experienced DRUG INTERACTION (IMBRUVICA OR THE CLL MADE  IT SO THAT THE COVID VACCINATION DID NOT CREATE ANTIBODIES). At the time of the report, DRUG INTERACTION (IMBRUVICA OR THE CLL MADE  IT SO THAT THE COVID VACCINATION DID NOT CREATE ANTIBODIES) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported. Treatment information was not provided. The reporter's causality for the event (s) of "IMBRUVICA OR THE CLL MADE IT SO THAT THE COVID VACCINATION DID NOT CREATE ANTIBODIES" with IMBRUVICA (IBRUTINIB) was a reasonable possibility.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: felt kind of blah; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt kind of blah) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt kind of blah). At the time of the report, FEELING ABNORMAL (felt kind of blah) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.    This case was linked to MOD21-088487, US-MODERNATX, INC.-MOD-2021-116586 (E2B Linked Report).; Sender's Comments:  MOD21-088487: US-MODERNATX, INC.-MOD-2021-116586:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Malaise, Rash, Rash erythematous
Clinical narrative: red rash patch on face; patient did not feel good; red rash patch on face; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face), RASH ERYTHEMATOUS (red rash patch on face) and MALAISE (patient did not feel good) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL for Blood pressure, ATORVASTATIN for Cholesterol, MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for Supplementation therapy.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face) and MALAISE (patient did not feel good). On an unknown date, the patient experienced RASH ERYTHEMATOUS (red rash patch on face). At the time of the report, HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face), RASH ERYTHEMATOUS (red rash patch on face) and MALAISE (patient did not feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment given included Benadryl.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Dyspnoea, Headache, Muscular weakness
Clinical narrative: Shortness of breath; Tightness in her chest; Body pain; Weakness; Pain in both legs; weakness in her legs; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness) and PAIN IN EXTREMITY (Pain in both legs) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2007321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment drugs were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Shortness of breath; Tightness in her chest; Body pain; Weakness; Pain in both legs; weakness in her legs; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness) and PAIN IN EXTREMITY (Pain in both legs) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2007321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment drugs were reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine). The report describes a case of VACCINATION COMPLICATION (Vaccination adverse reaction).    Co-suspect products included non-company products IBRUTINIB (IMBRUVICA) for Non-Hodgkin's lymphoma and IBRUTINIB (IMBRUVICA) for Non-Hodgkin's lymphoma.    No Medical History information was reported.  On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), IBRUTINIB (IMBRUVICA) (Oral) and IBRUTINIB (IMBRUVICA) (Oral) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was unknown if the patient was enrolled in Covid-19 vaccine trial.  The patient was treated with cetirizine (Zyrtec) .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Urticaria, Vaccination site pain, Vaccination site pruritus
Clinical narrative: injection area was itchy and slightly pain; hives on her non-injected arm, just above the elbow; airway started to constrict a little bit; injection area was itchy and slightly pain; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on her non-injected arm, just above the elbow), THROAT TIGHTNESS (airway started to constrict a little bit), VACCINATION SITE PRURITUS (injection area was itchy and slightly pain) and VACCINATION SITE PAIN (injection area was itchy and slightly pain) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced URTICARIA (hives on her non-injected arm, just above the elbow), THROAT TIGHTNESS (airway started to constrict a little bit) and VACCINATION SITE PRURITUS (injection area was itchy and slightly pain). On an unknown date, the patient experienced VACCINATION SITE PAIN (injection area was itchy and slightly pain). At the time of the report, URTICARIA (hives on her non-injected arm, just above the elbow), THROAT TIGHTNESS (airway started to constrict a little bit), VACCINATION SITE PRURITUS (injection area was itchy and slightly pain) and VACCINATION SITE PAIN (injection area was itchy and slightly pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Migraine, Nausea
Clinical narrative: migraines; arm of injection warm; arm of injection hard; arm of injection itchy; arm of injection red; Chills; tired; low grade temp 100.6F; slight nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraines), VACCINATION SITE WARMTH (arm of injection warm), VACCINATION SITE INDURATION (arm of injection hard), VACCINATION SITE PRURITUS (arm of injection itchy) and VACCINATION SITE ERYTHEMA (arm of injection red) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced MIGRAINE (migraines), VACCINATION SITE WARMTH (arm of injection warm), VACCINATION SITE INDURATION (arm of injection hard), VACCINATION SITE PRURITUS (arm of injection itchy), VACCINATION SITE ERYTHEMA (arm of injection red), CHILLS (Chills), FATIGUE (tired), PYREXIA (low grade temp 100.6F) and NAUSEA (slight nausea). The patient was treated with ACETAMINOPHEN for Migraine, at an unspecified dose and frequency. On 09-May-2021, MIGRAINE (migraines), CHILLS (Chills), FATIGUE (tired), PYREXIA (low grade temp 100.6F) and NAUSEA (slight nausea) had resolved. At the time of the report, VACCINATION SITE WARMTH (arm of injection warm), VACCINATION SITE INDURATION (arm of injection hard), VACCINATION SITE PRURITUS (arm of injection itchy) and VACCINATION SITE ERYTHEMA (arm of injection red) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Body temperature: 100.6 (High) low grade temp 100.6F.         Concomitant included vitamins and two medications for GERD ( unspecified)